amarteydd@gmail.com ; damdoku@ug.edu.gh

Research interest:

Interested in oncological drug discovery and development. Particular area of interest is in  the mechanisms of cancer development and progression, and cancer therapeutics with emphasis on the potential of therapeutic agents of medicinal plant sources.

Selected Publications:

• Asmah, R. H., Sackey, P., Adjei, P., Archampong, T. N., Attoh, S., Doku, D., Quarchie, M., Botchway, F., Adedia, D., & Donkor, E. S. (2022). Haematological Indices and Antioxidant Enzyme Activity in Ghanaian Stroke Patients. BioMed research international, 2022, 1203120.
• Santa, S., Doku, D. A., Olwal, C. O., Brown, C. A., Tagoe, E. A., & Quaye, O. (2022). Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19?. Future microbiology, 10.2217/fmb-2021-0233. Advance online publication.
• Asiedu, B., Anang, Y., Nyarko, A., Doku, D. A., Amoah, B. Y., Santa, S., Ngala, R. A., & Asare, G. A. (2017). The role of sex steroid hormones in benign prostatic hyperplasia. The aging male : the official journal of the International Society for the Study of the Aging Male, 20(1), 17–22.
• Asare, G. A., Ngala, R. A., Afriyie, D., Adjei, S., Nyarko, A., Anang-Quartey, Y., Asiedu, B., Doku, D., Amoah, B. Y., Bentum, K., Musah, I., & Mossanda, K. (2017). Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug - Croton membranaceus Müll.Arg. BMC complementary and alternative medicine, 17(1), 152. https://doi.org/10.1186/s12906-017-1663-x
• Asare, G. A., Akuffo, G., Doku, D., Asiedu, B., & Santa, S. (2016). Dynamics of urinary oxidative stress biomarkers: 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in uterine leiomyomas. Journal of mid-life health, 7(1), 8–14. https://doi.org/10.4103/0976-7800.179173
• Asare, G. A., Afriyie, D., Ngala, R. A., Abutiate, H., Doku, D., Mahmood, S. A., & Rahman, H. (2015). Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes. Integrative cancer therapies, 14(1), 65–74. https://doi.org/10.1177/1534735414550198